Expert commentary: A nurse educator’s view of the REWIND trial
Nurse educator Lori Berard gives her view of how the REWIND trial can help clinicians working with people with type 2 diabetes (1:48).
- News story | Dulaglutide cardioprotective in relatively low-risk REWIND population
- Expert commentary | The REWIND trial
- Expert commentary | A primary care view of the REWIND trial